Company · Skipton, North Yorkshire, United Kingdom
Dechra Ltd
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 24
- 23 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 19
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| COSACTHEN | 02498405 | Marketed | |
| DERMACHLOR 4 MOUSSE | 02494566 | Marketed | |
| DERMACHLOR 4 SHAMPOO | 02465779 | Marketed | |
| DERMACHLOR 4 SPRAY CONDITIONER | 02465760 | Marketed | |
| DERMACHLOR 4 WIPES | 02465787 | Marketed | |
| DUOTIC | 02556529 | Marketed | |
| EQUIPALAZONE 1 G | 02534517 | Marketed | |
| FELIMAZOLE 1.25 MG | 02411512 | Marketed | |
| FELIMAZOLE 2.5MG | 02332655 | Marketed | |
| FELIMAZOLE 5MG | 02332663 | Marketed | |
| HY-50 | 02238566 | Marketed | |
| MIRATAZ | 02504626 | Marketed | |
| OSPHOS INJECTION | 02440776 | Marketed | |
| OSURNIA | 02438534 | Marketed | |
| VETORYL 10 MG | 02322005 | Marketed | |
| VETORYL 120 MG | 02322056 | Marketed | |
| VETORYL 20 MG | 02551276 | Marketed | |
| VETORYL 30 MG | 02322021 | Marketed | |
| VETORYL 5 MG | 02457415 | Marketed | |
| VETORYL 60 MG | 02322048 | Marketed | |
| ZYCORTAL SUSPENSION | 02453657 | Marketed | |
| VETROPOLYCIN | 02431262 | Approved | |
| VETROPOLYCIN HC | 02431270 | Approved | |
| MALACETIC OTIC | 02261464 | Cancelled Post Market |
Notices of Compliance
Newest first.
- FELIMAZOLE 1.25 MG; FELIMAZOLE 2.5 MG; FELIMAZOLE 5 MGJune 10, 2026 · NOC 37681 · Supplement to a New Drug Submission (SNDS)
- DUOTICMarch 27, 2025 · NOC 35074 · New Drug Submission (NDS)
- VETORYL 20 MGAugust 30, 2024 · NOC 33895 · Supplement to a New Drug Submission (SNDS)
- TRI-SOLFENJune 21, 2022 · NOC 28425 · New Drug Submission (NDS)
- OSURNIASeptember 16, 2020 · NOC 24232 · New Drug Submission (NDS)
- MIRATAZSeptember 8, 2020 · NOC 24187 · New Drug Submission (NDS)
- COSACTHENApril 27, 2020 · NOC 23516 · New Drug Submission (NDS)
- OSPHOS INJECTIONMarch 16, 2020 · NOC 23337 · Supplement to a New Drug Submission (SNDS)
- OSPHOS INJECTIONMay 7, 2019 · NOC 22132 · Supplement to a New Drug Submission (SNDS)
- VETORYL 10 MG; VETORYL 120 MG; VETORYL 30 MG; VETORYL 5MG; VETORYL 60 MGSeptember 7, 2016 · NOC 18448 · Supplement to a New Drug Submission (SNDS)
- ZYCORTAL SUSPENSIONApril 5, 2016 · NOC 17959 · New Drug Submission (NDS)
- HY-50March 9, 2016 · NOC 17853 · New Drug Submission (NDS)
- OSPHOS INJECTIONMay 6, 2015 · NOC 16873 · New Drug Submission (NDS)
- FELIMAZOLE 1.25 MGSeptember 5, 2013 · NOC 14703 · Supplement to a New Drug Submission (SNDS)
- FELIMAZOLEAugust 25, 2009 · NOC 10543 · New Drug Submission (NDS)
- VETORYL 30 MGJanuary 30, 2009 · NOC 10016 · New Drug Submission (NDS)
- VETORYL 120 MGJanuary 30, 2009 · NOC 10017 · New Drug Submission (NDS)
- VETORYL 60 MGJanuary 30, 2009 · NOC 10018 · New Drug Submission (NDS)
- VETORYL 10 MGJanuary 30, 2009 · NOC 10019 · New Drug Submission (NDS)
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- Osurnia gel (2018-10-04)October 4, 2018 · Drugs - Veterinary drugs · Product safety · Type II